Variable Heavy Chain Domain Derived from a Cell-Penetrating Anti-DNA Monoclonal Antibody for the Intracellular Delivery of Biomolecules

References

• Alarcon-Segovia D, Ruiz-Arguelles A, Fishbein E. 1978. Antibody to nuclear ribonucleoprotein penetrates live human mononuclear cells through Fc receptors. Nature, 271, 67–69.
   PubMed Web of Science ®Google Scholar
• Alekseev OM, Richardson RT, Tsuruta JK, O’Rand MG. 2011. Depletion of the histone chaperone tNASP inhibits proliferation and induces apoptosis in prostate cancer PC-3 cells. Reprod Biol Endocrinol, 9, 50–62.
   PubMed Web of Science ®Google Scholar
• Avrameas A, Ternynck T, Nato F, et al. 1998. Polyreactive anti-DNA monoclonal antibodies and a derived peptide as vectors for the intracytoplasmic and intranuclear translocation of macromolecules. Proc Natl Acad Sci USA, 95, 5601–5606.
   PubMed Web of Science ®Google Scholar
• Brummelkamp TR, Bernards R, Agami R. 2002. Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell, 2, 243–247.
   PubMed Web of Science ®Google Scholar
• Chou ST, Mixson AJ. 2014. SiRNA nanoparticles: The future of RNAi therapeutics for oncology? (Review). Nanomedicine, 9, 2251–2254.
   PubMed Web of Science ®Google Scholar
• de Jong WH, Borm PJA. 2008. Drug delivery and nanoparticles: Applications and hazards (Review). International Journal of Nanomedicine, 3, 133–149.
   PubMed Web of Science ®Google Scholar
• Dunn WA, Hubbard AL, Aronson NN, Jr. 1980. Low temperature selectively inhibits fusion between pinocytic vesicles and lysosomes during heterophagy of 125I-asialofetuin by the perfused rat liver. J Biol Chem, 255, 5971–5978.
   PubMed Web of Science ®Google Scholar
• Dutta D, Donaldson JG. 2012. Search for inhibitors of endocytosis: Intended specificity and unintended consequences. Cell Logist, 2, 203–208.
   PubMedGoogle Scholar
• Fang J, Wang H, Xi W, et al. 2015. Downregulation of tNASP inhibits proliferation through regulating cell cycle-related proteins and inactive ERK/MAPK signal pathway in renal cell carcinoma cells. Tumour Biol, 36, 5209–5214.
   PubMed Web of Science ®Google Scholar
• Fang SL, Fan TC, Fu HW, et al. 2013. A novel cell-penetrating peptide derived from human eosinophil cationic protein. PLoS One, 8, e57318.
   PubMed Web of Science ®Google Scholar
• Frigerio B, Fracasso G, Luison E, et al. 2013. A single-chain fragment against prostate specific membrane antigen as a tool to build theranostic reagents for prostate cancer. Eur J Cancer, 49, 2223–2232.
   PubMed Web of Science ®Google Scholar
• Hsieh SC, Sun KH, Tsai CY, et al. 2001. Monoclonal anti-double stranded DNA antibody is a leucocyte-binding protein to up-regulate interleukin-8 gene expression and elicit apoptosis of normal human polymorphonuclear neutrophils. Rheumatology (Oxford), 40, 851–858.
   PubMed Web of Science ®Google Scholar
• Im SR, Im SW, Chung HY, et al. 2015. Cell- and nuclear-penetrating anti-dsDNA autoantibodies have multiple arginines in CDR3 of VH and increase cellular level of pERK and Bcl-2 in mesangial cells. Mol Immunol, 67, 377–387.
   PubMed Web of Science ®Google Scholar
• Jang EJ, Nahm DH, Jang YJ. 2009a. Mouse monoclonal autoantibodies penetrate mouse macrophage cells and stimulate NF-kappaB activation and TNF-alpha release. Immunol Lett, 124, 70–76.
   PubMed Web of Science ®Google Scholar
• Jang JY, Jeong JG, Jun HR, et al. 2009b. A nucleic acid-hydrolyzing antibody penetrates into cells via caveolae-mediated endocytosis, localizes in the cytosol and exhibits cytotoxicity. Cell Mol Life Sci, 66, 1985–1997.
   PubMed Web of Science ®Google Scholar
• Jang YJ, Lecerf JM, Stollar BD. 1996. Heavy chain dominance in the binding of DNA by a lupus mouse monoclonal autoantibody. Mol Immunol, 33, 197–210.
   PubMed Web of Science ®Google Scholar
• Jang YJ, Sanford D, Chung HY, et al. 1998. The structural basis for DNA binding by an anti-DNA autoantibody. Mol Immunol, 35, 1207–1217.
   PubMed Web of Science ®Google Scholar
• Jang YJ, Stollar BD. 1990. Ultraviolet cross-linking of helical oligonucleotides to two monoclonal MRL-1pr/1pr anti-DNA autoantibodies. Variations in H and L chain binding to DNA. J Immunol, 145, 3353–3359.
   Google Scholar
• Kijanka M, Dorresteijn B, Oliveira S, van Bergen en Henegouwen PM. 2015. Nanobody-based cancer therapy of solid tumors. Nanomedicine (Lond), 10, 161–174.
   Google Scholar
• Kim A, Shin TH, Shin SM, et al. 2012. Cellular internalization mechanism and intracellular trafficking of filamentous M13 phages displaying a cell-penetrating transbody and TAT peptide. PLoS One, 7, e51813.
   PubMed Web of Science ®Google Scholar
• Koren E, Koscec M, Wolfson-Reichlin M, et al. 1995. Murine and human antibodies to native DNA that cross-react with the A and D SnRNP polypeptides cause direct injury of cultured kidney cells. J Immunol, 154, 4857–4864.
   PubMed Web of Science ®Google Scholar
• Kubota T, Watanabe N, Kanai Y, Stollar BD. 1996. Enhancement of oxidative cleavage of DNA by the binding sites of two anti-double-stranded DNA antibodies. J Biol Chem, 271, 6555–65561.
   PubMed Web of Science ®Google Scholar
• Lee EJ, Jang EJ, Lee E, et al. 2007. Cell-penetrating autoantibody induces caspase-mediated apoptosis through catalytic hydrolysis of DNA. Bioorg Med Chem, 15, 2016–2023.
   PubMed Web of Science ®Google Scholar
• Lee WR, Jang JY, Kim JS, et al. 2010. Gene silencing by cell-penetrating, sequence-selective and nucleic-acid hydrolyzing antibodies. Nucleic Acids Res, 38, 1596–1609.
   PubMed Web of Science ®Google Scholar
• Li T, Bourgeois JP, Celli S, et al. 2012. Cell-penetrating anti-GFAP VHH and corresponding fluorescent fusion protein VHH-GFP spontaneously cross the blood-brain barrier and specifically recognize astrocytes: Application to brain imaging. FASEB J, 26, 3969–3979.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods, 25, 402–408.
   PubMed Web of Science ®Google Scholar
• Madaio MP, Fabbi M, Tiso M, et al. 1996. Spontaneously produced anti-DNA/DNase I autoantibodies modulate nuclear apoptosis in living cells. Eur J Immunol, 26, 3035–3041.
   PubMed Web of Science ®Google Scholar
• Mahajan SD, Aalinkeel R, Reynolds JL, et al. 2012. Suppression of MMP-9 expression in brain microvascular endothelial cells (BMVEC) using a gold nanorod (GNR)-siRNA nanoplex. Immunol Invest, 41, 337–355.
   PubMed Web of Science ®Google Scholar
• Marschall AL, Frenzel A, Schirrmann T, et al. 2011. Targeting antibodies to the cytoplasm. MAbs, 3, 3–16.
   PubMed Web of Science ®Google Scholar
• Mortensen ES, Fenton KA, Rekvig OP. 2008. Lupus nephritis: The central role of nucleosomes revealed. Am J Pathol, 172, 275–283.
   PubMed Web of Science ®Google Scholar
• Muller S, Zhao Y, Brown TL, et al. 2005. TransMabs: Cell-penetrating antibodies, the next generation. Expert Opin Biol Ther, 5, 237–241.
   PubMed Web of Science ®Google Scholar
• Nelson AL. 2010. Antibody fragments: Hope and hype. MAbs, 2, 77–83.
   PubMed Web of Science ®Google Scholar
• Palanca-Wessels MC, Booth GC, Convertine AJ, et al. 2016. Antibody targeting facilitates effective intratumoral siRNA nanoparticle delivery to HER2-overexpressing cancer cells. Oncotarget, 7, 9561–9575.
   PubMed Web of Science ®Google Scholar
• Patel LN, Zaro JL, Shen WC. 2007. Cell penetrating peptides: intracellular pathways and pharmaceutical perspectives. Pharm Res, 24, 1977–1992.
   PubMed Web of Science ®Google Scholar
• Rahbarizadeh F, Ahmadvand D, Sharifzadeh Z. 2011. Nanobody: An old concept and new vehicle for immunotargeting. Immunol Invest, 40, 299–338.
   PubMed Web of Science ®Google Scholar
• Reischl D, Zimmer A. 2009. Drug delivery of siRNA therapeutics: Potentials and limits of nanosystems. Nanomedicine, 5, 8–20.
   PubMed Web of Science ®Google Scholar
• Richardson RT, Batova IN, Widgren EE, et al. 2000. Characterization of the histone H1-binding protein, NASP, as a cell cycle-regulated somatic protein. J Biol Chem, 275, 30378–30386.
   PubMed Web of Science ®Google Scholar
• Rodrigo G, Gruvegård M, Van Alstine J. 2015. Antibody fragments and their purification by protein L affinity chromatography. Antibodies, 4, 259–277.
   Web of Science ®Google Scholar
• Schmidt-Acevedo S, Perez-Romano B, Ruiz-Arguelles A. 2000. ‘LE cells’ result from phagocytosis of apoptotic bodies induced by antinuclear antibodies. J Autoimmun, 15, 15–20.
   PubMed Web of Science ®Google Scholar
• Silverstein SC, Steinman RM, Cohn ZA. 1977. Endocytosis. Annu Rev Biochem, 46, 669–722.
   PubMed Web of Science ®Google Scholar
• Song E, Lee SK, Wang J, et al. 2003. RNA interference targeting Fas protects mice from fulminant hepatitis. Nat Med, 9, 347–351.
   PubMed Web of Science ®Google Scholar
• Sontheimer EJ. 2005. Assembly and function of RNA silencing complexes. Nat Rev Mol Cell Biol, 6, 127–138.
   PubMed Web of Science ®Google Scholar
• Studzian M, Bartosz G, Pulaski L. 2015. Endocytosis of ABCG2 drug transporter caused by binding of 5D3 antibody: Trafficking mechanisms and intracellular fate. Biochim Biophys Acta, 1853, 1759–1771.
   PubMed Web of Science ®Google Scholar
• Thueng-in K, Thanongsaksrikul J, Srimanote P, et al. 2012. Cell penetrable humanized-VH/V(H)H that inhibit RNA dependent RNA polymerase (NS5B) of HCV. PLoS One, 7, e49254.
   PubMed Web of Science ®Google Scholar
• Urban-Klein B, Werth S, Abuharbeid S, et al. 2005. RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo. Gene Ther, 12, 461–466.
   PubMed Web of Science ®Google Scholar
• Ustinov VA, Studennikov, AE, Vavilov VA, et al. 2015. Generation and characterization of human single-chain antibodies against polycyclic aromatic hydrocarbons. Immunol Invest, 44, 536–552.
   PubMed Web of Science ®Google Scholar
• Weisbart RH, Gera JF, Chan G, et al. 2012. A cell-penetrating bispecific antibody for therapeutic regulation of intracellular targets. Mol Cancer Ther, 11, 2169–2173.
   PubMed Web of Science ®Google Scholar
• Yung S, Chan TM. 2008. Anti-DNA antibodies in the pathogenesis of lupus nephritis-the emerging mechanisms. Autoimmun Rev, 7, 317–321.
   PubMed Web of Science ®Google Scholar
• Yung S, Tsang RC, Sun Y, et al. 2005. Effect of human anti-DNA antibodies on proximal renal tubular epithelial cell cytokine expression: Implications on tubulointerstitial inflammation in lupus nephritis. J Am Soc Nephrol, 16, 3281–3294.
   PubMed Web of Science ®Google Scholar